You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛美客(300896.SZ):擬收購融知生物少數股東所持49%權益
格隆匯 02-08 21:49

格隆匯 2 月 8日丨愛美客(300896.SZ)公佈,公司2021 28召開第屆董事會第十次會議審議通過了《關於收購控股子公司北京融知生物少數股東權益的議案》同意公司以現金支付方式收購北京融知生物科技有限公司(“融知生物”、“目標公司”)少數股東所持49%權益,收購價款合計人民幣342.81萬元。

目標公司估值較高的風險。根據評估報吿,目標公司全部股東權益價值697.58萬元。截至評估基準日,淨資產賬面價值-169.99萬元評估增值867.57萬元,增值率為510.37%

目標公司為研發類型的子公司,研發的項目溶脂藥和局部麻醉藥處於臨牀前階段具有一定的不確定性,面臨產品研發和註冊風險。

次交易完成後,公司所持有的融知生物權益比例由51%提高至100%,並由公司控股子公司變更為公司全資子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account